Bergen, Norway, October 2nd, 2023: Lifecare AS (LIFE), a clinical stage medical
sensor company developing the next generation Continuous Glucose Monitor (CGM))
has now placed the purchase order for automated production software. 

Reference is made to Lifecare's list of trigger events, as presented at the
semi-annual report of August 20th 2023 and later investor communication. The
launch of an automated production line by end of Q2 2024 is set as a major
milestone. To accomplish this, the company has decided on the preferred partner
and supplier of essential production machines and concluded to apply customized
Scanning Electron Microscopes from Carl Zeiss IQS Deutschland GmbH (Zeiss) as
the best cornerstone equipment for the upcoming automated production.

The software order to Zeiss for automated production software is the result of
longer negotiations for clarification of overall customization and adaptation
potentials. Following the delivery, the Lifecare NanoBioSensors team in
Reutlingen Germany will initiate the customization efforts for the final
automated production of Lifecare Sencell sensors. Automated pilot production is
initially planned with the Scanning Electron Microscopes of
Naturwissenschaftliches und Medizinisches Institut ("NMI") at the University of
Tübingen Germany, to which Lifecare has access through an existing cooperation
agreement.

Negotiations with Zeiss are further proceeding to finalize the specification,
price and lead time of the Scanning Electron Microscopes is expected to be
finalized in Q4 2023 for the purchase of hardware. The timeline allows for
launch of the automated production line and entry to veterinary market by end of
Q2 2024.

******

Lifecare AS is a clinical stage medical sensor company developing technology for
sensing and monitoring of various body analytes. Lifecare's main focus is to
bring the next generation of Continuous Glucose Monitoring ("CGM") systems to
market. Lifecare enables osmotic pressure as sensing principle, combined with
the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on
the sensor body for read-out of pressure variations. LifecareŽs sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the human
body.

******

For further information, please contact: 

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,
asle.wingsternes@lifecare.no, +47 41 61 42 52

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5-12 the Norwegian Securities Trading Act.